Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Zelicapavir
2. 2070852-76-3
3. (3s)-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
4. Zelicapavir [inn]
5. Zelicapavir (usan/inn)
6. U4oi721dmd
7. Chembl4475481
8. Schembl20098421
9. Vggnpznytjxpew-hszrjfapsa-n
10. Bdbm561716
11. Us11390631, Example 253
12. Us11390631, Example 442
13. Us11390631, Example 443
14. Da-77569
15. Ms-30056
16. Hy-147346
17. Cs-0566942
18. D12958
19. F84547
Molecular Weight | 549.5 g/mol |
---|---|
Molecular Formula | C27H22F3N7O3 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 5 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 118 |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 912 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
59
PharmaCompass offers a list of Zelicapavir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zelicapavir manufacturer or Zelicapavir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zelicapavir manufacturer or Zelicapavir supplier.
PharmaCompass also assists you with knowing the Zelicapavir API Price utilized in the formulation of products. Zelicapavir API Price is not always fixed or binding as the Zelicapavir Price is obtained through a variety of data sources. The Zelicapavir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zelicapavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zelicapavir, including repackagers and relabelers. The FDA regulates Zelicapavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zelicapavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zelicapavir supplier is an individual or a company that provides Zelicapavir active pharmaceutical ingredient (API) or Zelicapavir finished formulations upon request. The Zelicapavir suppliers may include Zelicapavir API manufacturers, exporters, distributors and traders.
Zelicapavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zelicapavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zelicapavir GMP manufacturer or Zelicapavir GMP API supplier for your needs.
A Zelicapavir CoA (Certificate of Analysis) is a formal document that attests to Zelicapavir's compliance with Zelicapavir specifications and serves as a tool for batch-level quality control.
Zelicapavir CoA mostly includes findings from lab analyses of a specific batch. For each Zelicapavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zelicapavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Zelicapavir EP), Zelicapavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zelicapavir USP).